Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-19.

Shuhei AzekawaShotaro ChubachiTakanori AsakuraHo NamkoongYasunori SatoRyuya EdahiroHo LeeHiromu TanakaShiro OtakeKensuke NakagawaraTakahiro FukushimaMayuko WataseKaori SakuraiTatsuya KusumotoKatsunori MasakiHirofumi KamataMakoto IshiiNaoki HasegawaYukinori OkadaRyuji KoikeYuko KitagawaAkinori KimuraSeiya ImotoSatoru MiyanoSeishi OgawaTakanori KanaiKoichi Fukunaganull null

Published in: BMJ open respiratory research (2023)

variant. Therefore, serum KL-6 level is a potentially useful biomarker of critical COVID-19 outcomes.

Keyphrases

coronavirus disease
sars cov
weight loss
skeletal muscle
insulin resistance